Outcomes of nonsuspicious contralateral nodules with active surveillance after lobectomy in patients with papillary thyroid carcinoma

被引:4
|
作者
Huang, Hui [1 ]
Liu, Jie [1 ]
Wang, Xiaolei [1 ]
Liu, Shaoyan [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Head & Neck Surg Oncol, Beijing, Peoples R China
来源
关键词
thyroid nodules; thyroid cancer; papillary carcinoma; thyroidectomy; active surveillance; NATURAL-HISTORY; CANCER; RISK; MICROCARCINOMA; PREVALENCE; VOLUME;
D O I
10.3389/fendo.2022.941080
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveTo observe the outcomes of nonsuspicious contralateral nodules with active surveillance in patients with papillary thyroid carcinoma (PTC). Methods4pt?>Consecutive patients who underwent lobectomy for PTC were retrospectively reviewed. Patients with one or more nodules with nonsuspicious ultrasonography (US) features in the contralateral lobe were included. ResultsTwo hundred and eighty-three patients were included. All patients underwent thyroid lobectomy with ipsilateral prophylactic central neck dissection. A total of 123 patients (43.5%) were classified as ATA low-risk, and 160 patients (56.5%) were classified as intermediate-risk. The median size of the contralateral nodules was 3 mm (range, 2 to 16 mm). After a period of follow-up, the median size change of contralateral nodules was 0 mm (range, -7 to 8 mm). Eight patients (2.8%) had nodule growth >3 mm, 223 patients (78.8%) had stable or decreased nodules, and 52 patients (18.4%) had no detectable nodules. Nodules in 24 patients had suspicious US features, 16 of which were diagnosed with PTMC by either cytology after FNA (in 7 patients) or histopathology after completion thyroidectomy (in 9 patients). Another four patients received completion thyroidectomy for ipsilateral cervical lymph node metastasis. The 5-year residual lobe recurrence (RLR) rate and recurrence-free survival (RFS) rate were 7.4% and 89.8%, respectively. Multivariate analysis showed that multifocality and ATA intermediate-risk were independent predictors for RLR (HR4.083, 95%CI 1.480-11.261, P = 0.007; HR 6.045, 95%CI 1.370-26.662, P = 0.017, respectively) and RFS (HR 5.240, 95%CI 2.114-12.991, P < 0.001; HR 5.223, 95%CI 1.353-17.765, P = 0.008, respectively). ConclusionsActive surveillance for nonsuspicious contralateral nodules in patients with low-risk and selected intermediate-risk PTC is safe. Multifocality and ATA intermediate-risk are predicters for recurrence. Early detection and salvage surgery are effective.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Serum thyroglobulin testing after thyroid lobectomy in patients with 1-4 cm papillary thyroid carcinoma
    Jang, Ahreum
    Jin, Meihua
    Kim, Chae A.
    Jeon, Min Ji
    Lee, Yu-Mi
    Sung, Tae-Yon
    Kim, Tae Yong
    Kim, Won Bae
    Shong, Young Kee
    Kim, Won Gu
    ENDOCRINE, 2023, 81 (02) : 290 - 297
  • [22] Surgery for Papillary Thyroid Carcinoma Is Lobectomy Enough?
    Mendelsohn, Abie H.
    Elashoff, David A.
    Abemayor, Elliot
    St John, Maie A.
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2010, 136 (11) : 1055 - 1061
  • [23] Surveillance and Intervention After Thyroid Lobectomy
    Spanheimer, Philip M.
    Sugg, Sonia L.
    Lal, Geeta
    Howe, James R.
    Weigel, Ronald J.
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (06) : 1729 - 1733
  • [24] Surveillance and Intervention After Thyroid Lobectomy
    Philip M. Spanheimer
    Sonia L. Sugg
    Geeta Lal
    James R. Howe
    Ronald J. Weigel
    Annals of Surgical Oncology, 2011, 18 : 1729 - 1733
  • [25] Outcomes of active surveillance of EU-TIRADS 5 thyroid nodules
    Rozenbaum, A.
    Buffet, C.
    Bigorgne, C.
    Royer, B.
    Rouxel, A.
    Bienvenu, M.
    Chereau, N.
    Menegaux, F.
    Leenhardt, L.
    Russ, G.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 184 (05) : 677 - 686
  • [26] Lymphovascular invasion of papillary thyroid carcinoma revisited in the era of active surveillance
    Cheng, Shih-Ping
    Lee, Jie-Jen
    Chien, Ming-Nan
    Kuo, Chi-Yu
    Jhuang, Jie-Yang
    Liu, Chien-Liang
    EJSO, 2020, 46 (10): : 1814 - 1819
  • [27] Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance
    Ho, Allen S.
    Luu, Michael
    Zalt, Cynthia
    Morris, Luc G. T.
    Chen, Irene
    Melany, Michelle
    Ali, Nabilah
    Patio, Chrysanta
    Chen, Yufei
    St-Clair, Jon Mallen
    Braunstein, Glenn D.
    Sacks, Wendy L.
    Zumsteg, Zachary S.
    THYROID, 2019, 29 (10) : 1409 - 1417
  • [28] Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Carcinoma
    Oh, Hye-Seon
    Kwon, Hyemi
    Song, Eyun
    Jeon, Min Ji
    Kim, Tae Yong
    Lee, Jeong Hyun
    Kim, Won Bae
    Shong, Young Kee
    Chung, Ki-Wook
    Baek, Jung Hwan
    Kim, Won Gu
    THYROID, 2019, 29 (05) : 642 - 649
  • [29] Active surveillance of papillary thyroid carcinoma in Latin America: a scoping review
    Manfio, Pedro Garnier
    Chinelatto, Lucas Albuquerque
    Hojaij, Flavio Carneiro
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2024, 68
  • [30] Predicting disease-specific survival in patients undergoing active surveillance for papillary thyroid carcinoma
    Nielsen, Stanton
    Kuchta, Kristine
    Huang, Grace
    Zuber, Samuel
    Holoubek, Simon
    Karcioglu, Amanda
    Khokar, Amna
    Prinz, Richard
    Moo-Young, Tricia
    WORLD JOURNAL OF SURGERY, 2025, 49 (04) : 1011 - 1021